Teva snaps six straight sessions of gains
Teva Pharmaceutical Industries (TEVA) shares snapped six straight sessions of gains, as the stock closed 0.4% lower at...
Tag: TEVA
Earnings Snapshot: Teva Pharmaceutical Industries tops Q4 estimates; initiates FY26 outlook below forecast
*Other Operating Data Consensus Source: Bloomberg
Teva projects revenue drop in 2026 despite Q4 beat
Teva Pharmaceutical (TEVA) traded lower in the premarket on Wednesday after the generic drugmaker projected...
Teva Pharmaceutical Non-GAAP EPS of $0.96 beats by $0.32, revenue of $4.71B beats by $380M
Teva Pharmaceutical press release (TEVA): Q4 Non-GAAP EPS of $0.96 beats by $0.32. Revenue of $4.71B (+11.3% Y/Y) beats by...
Teva Pharmaceutical Q4 2025 Earnings Preview
Teva Pharmaceutical (TEVA) is scheduled to announce Q4 earnings results on Wednesday, January 28th, before market open. The...
Novo sued for working with Teva to delay generic Victoza
A class action lawsuit was filed in New York federal court on Friday accusing Novo Nordisk (NVO) of running a...
Teva Pharmaceutical sees 2025 EPS at higher range of outlook
Teva Pharmaceutical Industries (TEVA) said that it anticipates its 2025 diluted EPS will be at the higher end of its...
Royalty Pharma promises $500M to Teva for advancing vitiligo treatment
Teva Pharmaceutical (TEVA) Industries and Royalty Pharma (RPRX) announced a $500M funding agreement to accelerate...
Alvotech, Teva reach settlement with Regeneron over Eylea biosimilar AVT06 in U.S.
Alvotech (ALVO) and Teva Pharmaceuticals (TEVA) have reached a settlement and license agreement with Regeneron...
Sagimet rises as licensing deal with Teva unit targets Madrigal drug
Shares of Sagimet Biosciences (SGMT) climbed on Wednesday after the company reached a license agreement with a subsidiary of...